\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\ unremarkable\\.\\ thyroid\\ normal\\.\\ lungs\\ clear\\.\\ cardiac\\ exam\\ wnl\\.\\ no\\ abdominal\\ masses\\.\\ \\ lan\\:\\ 24\\ hr\\ vma\\ 107\\.6\\ \\(0\\-10\\.0\\)\\,\\ epinephrine\\ 170\\ \\(\\.\\ 5\\-20\\)\\,\\ norepinephrine\\ 460\\ \\(15\\-18\\)\\ \\ total\\ catecholamines\\ 3196\\ \\(123\\-671\\ supine\\)\ \(0\)\
\-\ prazosin\\ 1mg\\ po\\ bid\\ prior\\ to\\ surgery\\ followed\\ by\\ surgical\\ excision\\.\\ \\ follow\\ up\\ with\\ repeat\\ vma\\ and\\ metanephrines\\ and\\ imaging\\ studies\\.\\ \\ if\\ the\\ pheochromocytoma\\ is\\ malignant\\,\\ as\\ evidenced\\ by\\ invasion\\ and\\ metastasis\\ then\\ treatment\\ is\\ primarily\\ surgical\\ with\\ chemotherapy\\ playing\\ only\\ a\\ palliative\\ role\\.\ \(0\)\
\-\ ct\\ chest\\ abd\\ pelvis\\ with\\ oral\\ and\\ iv\\ contrast\\ large\\ soft\\ tissue\\ mass\\ arising\\ from\\ left\\ adrenal\\ gland\\ measuring\\ 9\\.5\\ x\\ 8\\.9\\ x\\ 13cm\\ in\\ the\\ oblique\\ coronal\\,\\ ap\\,\\ and\\ craniocaudal\\ dimensions\\.\\ \\ loss\\ of\\ tissue\\ plane\\ between\\ tail\\ of\\ pancreas\\,\\ spleen\\,\\ and\\ bowel\\.\ \(0\)\
\-\ pheochromocytoma\ \(23\)\
\-\ hyperthyroidism\\,\\ meduloblastoma\\,\\ soft\\ tissue\\ sarcoma\\,\\ incidentaloma\\,\\ myeloolipoma\\,\\ renal\\ cell\\ carcinoma\\,\\ adrenal\\ cortical\\ carcinoma\ \(0\)\
\-\ 30\\ y\\/o\\ male\\ with\\ no\\ significant\\ pmh\\ presents\\ with\\ symptoms\\ of\\ headache\\ and\\ flushing\\.\\ \\ was\\ discovered\\ to\\ have\\ bp\\ 250\\/140\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ vma\\:\\ 0\\.2550326919608834\ \(0\)\
\-\ pheochromocytoma\\:\\ 0\\.20897030001513878\ \(0\)\
\-\ adrenal\\:\\ 0\\.17120667625790753\ \(0\)\
\-\ 3196\\:\\ 0\\.14781529075106337\ \(0\)\
\-\ myeloolipoma\\:\\ 0\\.14781529075106337\ \(0\)\
\-\ tissue\\:\\ 0\\.1454596890444015\ \(0\)\
\-\ catecholamines\\:\\ 0\\.1412454015997365\ \(0\)\
\-\ prazosin\\:\\ 0\\.1412454015997365\ \(0\)\
\-\ 13cm\\:\\ 0\\.1412454015997365\ \(0\)\
\-\ incidentaloma\\:\\ 0\\.1412454015997365\ \(0\)\
\-\ 460\\:\\ 0\\.13658399106394264\ \(0\)\
\-\ meduloblastoma\\:\\ 0\\.13658399106394264\ \(0\)\
\-\ and\\:\\ 0\\.1336963322000611\ \(0\)\
\-\ lan\\:\\ 0\\.13296832015255886\ \(0\)\
\-\ metanephrines\\:\\ 0\\.13296832015255886\ \(0\)\
\-\ flushing\\:\\ 0\\.13296832015255886\ \(0\)\
\-\ epinephrine\\:\\ 0\\.13001410191261578\ \(0\)\
\-\ norepinephrine\\:\\ 0\\.1275163459804417\ \(0\)\
\-\ 1mg\\:\\ 0\\.1275163459804417\ \(0\)\
\-\ bid\\:\\ 0\\.116285046293321\ \(0\)\
\-\ carcinoma\\:\\ 0\\.11057459635981555\ \(0\)\
\-\ 170\\:\\ 0\\.10971515714199412\ \(0\)\
\-\ evidenced\\:\\ 0\\.10971515714199412\ \(0\)\
\-\ dimensions\\:\\ 0\\.10971515714199412\ \(0\)\
\-\ craniocaudal\\:\\ 0\\.10824111045644978\ \(0\)\
\-\ hyperthyroidism\\:\\ 0\\.10393583162699054\ \(0\)\
\-\ palliative\\:\\ 0\\.09968465415116937\ \(0\)\
\-\ soft\\:\\ 0\\.09841526300926709\ \(0\)\
\-\ role\\:\\ 0\\.09700981076932906\ \(0\)\
\-\ po\\:\\ 0\\.09471459922899607\ \(0\)\
\-\ plane\\:\\ 0\\.09325385032044867\ \(0\)\
\-\ exam\\:\\ 0\\.09305836380873278\ \(0\)\
\-\ supine\\:\\ 0\\.09270453193986981\ \(0\)\
\-\ tail\\:\\ 0\\.09116018865659918\ \(0\)\
\-\ with\\:\\ 0\\.09049450203649909\ \(0\)\
\-\ spleen\\:\\ 0\\.08997693753901963\ \(0\)\
\-\ surgical\\:\\ 0\\.0898477462000602\ \(0\)\
\-\ playing\\:\\ 0\\.08952681580670281\ \(0\)\
\-\ primarily\\:\\ 0\\.08866243272442512\ \(0\)\
\-\ pancreas\\:\\ 0\\.08687128510934351\ \(0\)\
\-\ wnl\\:\\ 0\\.0866839611691218\ \(0\)\
\-\ abd\\:\\ 0\\.08595559853187458\ \(0\)\
\-\ discovered\\:\\ 0\\.08426622189517029\ \(0\)\
\-\ pmh\\:\\ 0\\.08363688685636887\ \(0\)\
\-\ invasion\\:\\ 0\\.08244711659150308\ \(0\)\
\-\ repeat\\:\\ 0\\.08107312944653644\ \(0\)\
\-\ oblique\\:\\ 0\\.08005210888162886\ \(0\)\
\-\ hr\\:\\ 0\\.07944517124676943\ \(0\)\
\-\ by\\:\\ 0\\.0785020642654825\ \(0\)\
\-\ sarcoma\\:\\ 0\\.0775366926312364\ \(0\)\
\-\ total\\:\\ 0\\.07573446580863848\ \(0\)\
\-\ gland\\:\\ 0\\.07508438789397329\ \(0\)\
\-\ bp\\:\\ 0\\.07499361264052694\ \(0\)\
\-\ oral\\:\\ 0\\.0740272735127877\ \(0\)\
\-\ coronal\\:\\ 0\\.07360638386554412\ \(0\)\
\-\ arising\\:\\ 0\\.0734410422231058\ \(0\)\
\-\ excision\\:\\ 0\\.07287528209544256\ \(0\)\
\-\ thyroid\\:\\ 0\\.0726387327795546\ \(0\)\
\-\ measuring\\:\\ 0\\.07150516995715739\ \(0\)\
\-\ cardiac\\:\\ 0\\.06863632894337082\ \(0\)\
\-\ lungs\\:\\ 0\\.06821387155964871\ \(0\)\
\-\ studies\\:\\ 0\\.06780214929050617\ \(0\)\
\-\ metastasis\\:\\ 0\\.06774417663345432\ \(0\)\
\-\ clear\\:\\ 0\\.06700882034308113\ \(0\)\
\-\ ap\\:\\ 0\\.06635843174879365\ \(0\)\
\-\ cortical\\:\\ 0\\.06635843174879365\ \(0\)\
\-\ iv\\:\\ 0\\.06604277227849788\ \(0\)\
\-\ malignant\\:\\ 0\\.06588721901637254\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.0656312367515528\ \(0\)\
\-\ 24\\:\\ 0\\.06552996554463464\ \(0\)\
\-\ then\\:\\ 0\\.06542932335548117\ \(0\)\
\-\ pelvis\\:\\ 0\\.0646459277530555\ \(0\)\
\-\ headache\\:\\ 0\\.06371711532197655\ \(0\)\
\-\ 30\\:\\ 0\\.06305385736499428\ \(0\)\
\-\ masses\\:\\ 0\\.06292440255900227\ \(0\)\
\-\ followed\\:\\ 0\\.062416684561637105\ \(0\)\
\-\ unremarkable\\:\\ 0\\.061964851118450744\ \(0\)\
\-\ no\\:\\ 0\\.06011420531844159\ \(0\)\
\-\ between\\:\\ 0\\.06005637250291771\ \(0\)\
\-\ bowel\\:\\ 0\\.05931732986504567\ \(0\)\
\-\ only\\:\\ 0\\.0577448639128213\ \(0\)\
\-\ renal\\:\\ 0\\.05755861657074365\ \(0\)\
\-\ loss\\:\\ 0\\.056311590626651344\ \(0\)\
\-\ of\\:\\ 0\\.05426427832852862\ \(0\)\
\-\ if\\:\\ 0\\.0537039811187098\ \(0\)\
\-\ significant\\:\\ 0\\.053366900961144194\ \(0\)\
\-\ cell\\:\\ 0\\.0528740749241531\ \(0\)\
\-\ prior\\:\\ 0\\.051714606976380015\ \(0\)\
\-\ is\\:\\ 0\\.0506250294931881\ \(0\)\
\-\ symptoms\\:\\ 0\\.05057232283380813\ \(0\)\
\-\ abdominal\\:\\ 0\\.05055228159394786\ \(0\)\
\-\ physical\\:\\ 0\\.05011753174881007\ \(0\)\
\-\ follow\\:\\ 0\\.049827661042236904\ \(0\)\
\-\ surgery\\:\\ 0\\.04969414247328743\ \(0\)\
\-\ chest\\:\\ 0\\.04878910534184672\ \(0\)\
\-\ imaging\\:\\ 0\\.04857496116291676\ \(0\)\
\-\ large\\:\\ 0\\.046311892474689156\ \(0\)\
\-\ to\\:\\ 0\\.046214511406981205\ \(0\)\
\-\ have\\:\\ 0\\.04617372956912939\ \(0\)\
\-\ up\\:\\ 0\\.04572151397619569\ \(0\)\
\-\ contrast\\:\\ 0\\.04490972788711836\ \(0\)\
\-\ presents\\:\\ 0\\.044463480327630214\ \(0\)\
\-\ treatment\\:\\ 0\\.04402919395340494\ \(0\)\
\-\ male\\:\\ 0\\.041153279892453855\ \(0\)\
\-\ normal\\:\\ 0\\.03773844677158698\ \(0\)\
\-\ as\\:\\ 0\\.037132310561536826\ \(0\)\
\-\ the\\:\\ 0\\.03688616819501674\ \(0\)\
\-\ from\\:\\ 0\\.03670917770961018\ \(0\)\
\-\ mass\\:\\ 0\\.03530569670515278\ \(0\)\
\-\ ct\\:\\ 0\\.035188873269312054\ \(0\)\
\-\ was\\:\\ 0\\.03221268264247047\ \(0\)\
\-\ left\\:\\ 0\\.03152980329523984\ \(0\)\
\-\ in\\:\\ 0\\.022993521838774792\ \(0\)\
